These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1783 related items for PubMed ID: 37346073
1. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T, Luo Y, Liu J, Liu F, Ma Z, Liu G, Li H, Wen J, Chen C, Zeng X. Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [Abstract] [Full Text] [Related]
2. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C, Liu D, Wang F, Liu Y, Xie J, Xie J, Xie Y. Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [Abstract] [Full Text] [Related]
3. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Wang Y, Xu J, Fang Y, Gu J, Zhao F, Tang Y, Xu R, Zhang B, Wu J, Fang Z, Li Y. Front Immunol; 2022; 13():950001. PubMed ID: 36091041 [Abstract] [Full Text] [Related]
4. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. Ding D, Wang D, Qin Y. Medicine (Baltimore); 2023 Nov 17; 102(46):e36190. PubMed ID: 37986299 [Abstract] [Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X. Front Immunol; 2022 Nov 17; 13():1056932. PubMed ID: 36479114 [Abstract] [Full Text] [Related]
6. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J. J Gastrointest Oncol; 2022 Dec 17; 13(6):3169-3182. PubMed ID: 36636051 [Abstract] [Full Text] [Related]
7. Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification. Chen Z, Du D, Li J, Zhang W, Shao J. Transl Cancer Res; 2024 Mar 31; 13(3):1268-1289. PubMed ID: 38617510 [Abstract] [Full Text] [Related]
8. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Peng J, Xie Y. Front Cell Dev Biol; 2022 Mar 31; 10():971992. PubMed ID: 36081904 [Abstract] [Full Text] [Related]
11. Prognostic analysis of RAS-related lncRNAs in liver hepatocellular carcinoma. Li D, Fan X, Zuo L, Wu X, Wu Y, Zhang Y, Zou F, Sun Z, Zhang W. Ann Transl Med; 2022 Dec 31; 10(24):1356. PubMed ID: 36660710 [Abstract] [Full Text] [Related]
14. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis. He Q, Fan B, Du P, Jin Y. Front Cell Dev Biol; 2022 Dec 31; 10():806989. PubMed ID: 35356272 [Abstract] [Full Text] [Related]
15. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C. J Immunol Res; 2022 Dec 31; 2022():3393027. PubMed ID: 36438201 [Abstract] [Full Text] [Related]
17. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Song D, Zhou Z, Zhang D, Wu J, Hao Q, Zhao L, Ren H, Zhang B. Front Genet; 2022 Dec 31; 13():850200. PubMed ID: 35711939 [Abstract] [Full Text] [Related]
18. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma. Zhu XR, Zhu JQ, Chen YF, Liu YY, Lu JJ, Sun J, Peng SQ, Chen MB, Du YP. Front Oncol; 2022 Dec 31; 12():972744. PubMed ID: 35982956 [Abstract] [Full Text] [Related]